Green light at Merck facility boosts varicella vaccine supplies
September 9, 2013Manufacturing and Production Merck, Taylor, varicella
Prospects for Merck & Co’s vaccines for shingles and chickenpox have been lifted by approval of additional bulk manufacturing capacity …
Gedeon Richter named and shamed
September 9, 2013Medical Communications, Sales and Marketing ABPI, Gedeon Richter, PMCPA
Gedeon Richter (UK) has been named and shamed in advertisements by the PMCPA, which rules on breaches of the ABPI …
GSK has ‘serious concerns’ about China
September 9, 2013Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline is said to be thinking about abandoning China altogether as the company continues to co-operate with the country’s authorities …
SYNthesis med chem opens new facility in Cambridge
September 9, 2013Research and Development, Sales and Marketing Cambridge, China, SYNthesis med chem
Contract research organisation SYNthesis med chem has announced that it has joined the bio-medical cluster by opening a new facility …
RDC appoints director from Munro and Forster
September 9, 2013Medical Communications, Research and Development, Sales and Marketing RDC, claire grindal, munro and forster
Claire Grindal has joined Red Door Communications (RDC) as an associate director from Munro and Forster. Grindal was part of …
Untapping the unconscious: the next revolution in pharma marketing
September 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Strategic North, allman, pharma marketing, sharman
There has been a lot of doom and gloom about the pharmaceutical industry in recent years, with drying pipelines and …
Novartis signs Regenerex deal
September 9, 2013Sales and Marketing CLL, Novartis, kidney, regenerex
Novartis has signed a deal with US biopharma firm Regenerex to use its novel stem cell-based platform, which may have …
Manufacturing and production news in brief
September 6, 2013Manufacturing and Production GSK, Jabones Pardo, Mylan, Shasun, Wockhardt
A round-up of pharma manufacturing facility news, with updates from Wockhardt, Mylan, GSK and Shasun, plus an FDA warning letter …
GSK may sell Lucozade and Ribena to Japan’s Suntory
September 6, 2013Sales and Marketing GSK, Suntory, lucozde, ribena
GSK is reportedly to sell its Lucozade and Ribena brands to Osaka-based Suntory in a deal worth up to £1.5 …
China may be trying to ‘frighten’ pharma
September 6, 2013Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery
Western pharma companies caught up in Chinese probes over corruption are being discriminated against, according to a European business lobby …
Otsuka buys Astex for $866 million
September 6, 2013Sales and Marketing Astex, Lundbeck, Onyx, Otsuka
Otsuka Pharmaceutical is to buy UK-based Astex Pharmaceuticals in a deal that will see the Tokyo-based firm shelling out $866 …
NSF appoints senior director
September 6, 2013Manufacturing and Production, Research and Development, Sales and Marketing NSF, Toscano
Public health organisation NSF International has appointed George Toscano as senior director of Quality Systems, Pharmaceuticals, Biotech and Biologics. Toscano …
More cash for ‘paperless NHS’
September 5, 2013Medical Communications, Sales and Marketing DoH, Hunt, NHS, paper free
The government has announced £1 billion funding for IT projects to help deliver its commitment to a paperless NHS by …
NICE queries pharma R&D costs
September 5, 2013Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D
NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …
GSK cancer vaccine fails in Phase III
September 5, 2013Research and Development, Sales and Marketing BMS, GSK, Yervoy, melanoma, phase III
GlaxoSmithKline’s hopes of creating a cancer vaccine against the deadliest form of skin cancer took a blow today when its …
New leadership roles at Novella Clinical
September 5, 2013Manufacturing and Production, Research and Development, Sales and Marketing CRO, novella clinical
Contract research organisation Novella Clinical has announced that three senior executives have assumed new leadership roles within the firm. Deborah …
AstraZeneca begins olaparib programme
September 4, 2013Sales and Marketing AstraZeneca, olaparib, ovarian cancer
AstraZeneca has begun recruitment in its Phase III programme for olaparib, a potential first-in-class oral poly ADP ribose polymerase (PARP) …
Transparent implant opens ‘window’ on the brain
September 4, 2013Medical Communications, Research and Development, Sales and Marketing UC, YSZ, brain
Researchers have developed a cranial implant that could act as a brain ‘window’, making life-changing procedures safer and easier. The …
GSK faces new China allegations
September 4, 2013Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline is facing a potential worsening of its already embarrassing situation in China, where the UK-based group has been accused …
RSA hires Chris Molloy as chief executive
September 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Molley, rsa
Life sciences executive search and interim management firm RSA has announced the appointment of Chris Molloy as its chief executive. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
